These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15064761)

  • 1. A single class II myosin modulates T cell motility and stopping, but not synapse formation.
    Jacobelli J; Chmura SA; Buxton DB; Davis MM; Krummel MF
    Nat Immunol; 2004 May; 5(5):531-8. PubMed ID: 15064761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
    Kohlstedt K; Kellner R; Busse R; Fleming I
    Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
    Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
    Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
    Li Y; Friedmann DR; Mhatre AN; Lalwani AK
    Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
    Morimura S; Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
    Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M
    Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.
    Even-Ram S; Yamada KM
    Cell Adh Migr; 2007; 1(3):152-5. PubMed ID: 19262128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: association of the motor protein nonmuscle myosin heavy chain-IIA with the C terminus of the chemokine receptor CXCR4 in T lymphocytes.
    Rey M; Vicente-Manzanares M; Viedma F; Yáñez-Mó M; Urzainqui A; Barreiro O; Vázquez J; Sánchez-Madrid F
    J Immunol; 2002 Nov; 169(10):5410-4. PubMed ID: 12421915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Animal models of MYH9 disorders].
    Suzuki N; Kunishima S; Naoe T; Matsushita T
    Rinsho Ketsueki; 2013 Nov; 54(11):2031-7. PubMed ID: 24305535
    [No Abstract]   [Full Text] [Related]  

  • 10. T Lymphocyte Myosin IIA is Required for Maturation of the Immunological Synapse.
    Kumari S; Vardhana S; Cammer M; Curado S; Santos L; Sheetz MP; Dustin ML
    Front Immunol; 2012; 3():230. PubMed ID: 22912631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin IIA modulates T cell receptor transport and CasL phosphorylation during early immunological synapse formation.
    Yu Y; Fay NC; Smoligovets AA; Wu HJ; Groves JT
    PLoS One; 2012; 7(2):e30704. PubMed ID: 22347397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of T cell motility and arrest: deciphering the relationship between intra- and extracellular determinants.
    Friedman RS; Jacobelli J; Krummel MF
    Semin Immunol; 2005 Dec; 17(6):387-99. PubMed ID: 16219473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin-IIA and ICAM-1 regulate the interchange between two distinct modes of T cell migration.
    Jacobelli J; Bennett FC; Pandurangi P; Tooley AJ; Krummel MF
    J Immunol; 2009 Feb; 182(4):2041-50. PubMed ID: 19201857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular motors involved in T cell receptor clusterings.
    Krawczyk C; Penninger JM
    J Leukoc Biol; 2001 Mar; 69(3):317-30. PubMed ID: 11261777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons.
    Ma X; Kawamoto S; Hara Y; Adelstein RS
    Mol Biol Cell; 2004 Jun; 15(6):2568-79. PubMed ID: 15034141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modes and mechanisms of T cell motility: roles for confinement and Myosin-IIA.
    Krummel MF; Friedman RS; Jacobelli J
    Curr Opin Cell Biol; 2014 Oct; 30():9-16. PubMed ID: 24905977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
    Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myosin motor isoforms direct specification of actomyosin function by tropomyosins.
    Clayton JE; Pollard LW; Murray GG; Lord M
    Cytoskeleton (Hoboken); 2015 Mar; 72(3):131-45. PubMed ID: 25712463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYH9 binds to dNTPs via deoxyribose moiety and plays an important role in DNA synthesis.
    Nangia-Makker P; Shekhar MPV; Hogan V; Balan V; Raz A
    Oncotarget; 2022; 13():534-550. PubMed ID: 35309869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice.
    Matsushita T; Hayashi H; Kunishima S; Hayashi M; Ikejiri M; Takeshita K; Yuzawa Y; Adachi T; Hirashima K; Sone M; Yamamoto K; Takagi A; Katsumi A; Kawai K; Nezu T; Takahashi M; Nakashima T; Naoe T; Kojima T; Saito H
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1163-71. PubMed ID: 15555549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.